Agios Pharmaceuticals, Inc. (AGIO) Q2 2023 Earnings Call Transcript

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q2 2023 Results Conference Call August 3, 2023 8:00 AM ET

Company Participants

Christopher Taylor - Vice President of Investor Relations
Brian Goff - Chief Executive Officer
Sarah Gheuens - Chief Medical Officer and Head of Research and Development
Tsveta Milanova - Chief Commercial Officer
Cecilia Jones - Chief Financial Officer

Conference Call Participants

Greg Harrison - Bank of America
Gregory Renza - RBC Capital Markets
Divya Rao - TD Cowen
Andy Berens - Leerink
Tess Romero - JP Morgan
Danielle Brill - Raymond James

Operator

Good morning, and welcome to Agios’ Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end. Please be advised that this call is being recorded at Agios’ request.

I would now like to turn the call over to Chris Taylor, Vice President, Investor Relations & Corporate Communications for Agios.

Christopher Taylor

Thank you, operator. Good morning, everyone, and welcome to Agios second quarter 2023 conference call. You can access slides for today’s call by going to the Investors section of our website, agios.com.

On today’s call, I’m joined by our Chief Executive Officer, Brian Goff; Dr. Sarah Gheuens, our Chief Medical Officer and Head of Research and Development; Tsveta Milanova, our Chief Commercial Officer; and Cecilia Jones, Chief Financial Officer.

Before we get started, I would like to remind everyone that some of the statements we make on this call will include forward-looking statements, actual events and results could differ materially from those expressed or implied by any forward-looking statements as a result of risks, uncertainties, and other factors, including those set forth in our most recent filings with the SEC and any other future filings that we may make with the SEC.

And with that, I